Global Insulin Glargine Market Survey and Trend Research 2018

ReportPage
Report ID
2089
Published Date
10-Dec
No of Report Page
91
Report Category
Editor's Rating
US $5,200.00
US $5,200.00
US $2,600.00

  • Report Details

    Summary
    Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
    This report describe

    More...
  • Table Of Content

    Table of Content
    Part 1 Industry Overview
    1.1 Insulin Glargine Industry
    1.1.1 Definition
    1.1.2 Industry Trend
    1.2 Industry Chain
    1.2.1 Upstream
    1.2.2 Technology
    1.2.3 Cost Structure
    1.2.4 Consumer Preference
    1.2.2 Downstream
    Part 2 Industry Overall
    2.1 Industry History
    2.2 Development Prospect
    2.3 Competition Structure

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample